Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

NCT02242383 · clinicaltrials.gov ↗

COMPLETED

Status

13248

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Telmisartan in combination with hydrochlorothiazide

Sponsor

Boehringer Ingelheim